Cutaneous and Mucosal Side Effects of New Anticancer Drugs: EGF-R Inhibitors, Tyrosine Kinase Inhibitors, and Mitotic Spindle Stabilizers
January 2011
EGF-R inhibitors tyrosine kinase inhibitors mitotic spindle stabilizers Sorafenib Sunitinib Imatinib hand-foot syndrome subungual haemorrhages hair texture changes hair loss erythema Cetuximab Erlotinib papulo-pustular eruptions xerosis fine hair brittle hair frizzy hair androgenetic alopecia hair color changes trichomegaly ciliary taxanes mucositis stomatitis onycholysis hyperpigmentation hypopigmentation alopecia scleroderma Nexavar Sutent Gleevec nail hemorrhages skin redness Erbitux Tarceva skin eruptions dry skin male pattern baldness long eyelashes mouth sores mouth inflammation nail separation darkened nails lightened nails hardened skin
Studysummary This article discusses the various skin side effects associated with targeted cancer therapies like tyrosine kinase inhibitors and EGF-R inhibitors but provides no new clinical findings.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on dial.uclouvain.be →